Lv1
30 积分 2025-09-11 加入
Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease
16小时前
待确认
Hepatic Outcomes in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease: Propensity-Matched Cohort Study
1个月前
已完结
Effects of GLP-1 Receptor Agonists on Muscle Mass, Strength, and Quality in MASLD: A Systematic Review
1个月前
已关闭
Impact of PNPLA3 in Lean Individuals and in Cryptogenic Steatotic Liver Disease
1个月前
已完结
Central obesity measured by weight-adjusted waist index is associated with lean MASLD
1个月前
已完结
Clinical and anthropometric characteristics of non‐obese non‐alcoholic fatty liver disease subjects in Japan
1个月前
已完结
Waist Circumference as a Predictor of Hepatic Steatosis and Fibrosis in the NHANES 2017-2018 Cohort
1个月前
已完结
Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Population‐Based Cohort Study
1个月前
已完结
Lean nonalcoholic fatty liver disease: Age‐dependent differences in pathology, prognosis, and liver‐related events
1个月前
已完结
Current Burden of Lean Metabolic Dysfunction‐Associated Steatotic Liver Disease Among US Adults, 2017–2023
1个月前
已完结
皖公网安备34019202002308
